Mark Sciegaj, PhD

Articles

October 30th 2024

Understanding the Financial Return to Investments in the Social Determinants of Health

Dennis P. Scanlon, PhD Mark Sciegaj, PhD

The policy community should consider these concrete suggestions to address the challenges presented by social determinants of health.

September 18th 2019

Achieving a Culture of Health: Steps for Engaging State Government

Dennis P. Scanlon, PhD Jocelyn M. Vanderbrink, MHA Mark Sciegaj, PhD Brigitt Leitzell, MS

Based on findings from a 2-state exploratory study, the authors articulate research-informed action steps for promoting state government roles in the pursuit of a culture of health.

June 1st 1999

Use of Performance Standards in Behavioral Health Carve-Out Contracts Among Fortune 500 Firms

Elizabeth L. Merrick, PhD, MSW Deborah W. Garnick, ScD Constance M. Horgan, ScD David Goldin, MA Dominic Hodgkin, PhD Mark Sciegaj, PhD

Latest Updated Articles

FDA approval stamp | Image Credit: Surendra - stock.adobe.com

Published: November 15th 2024 | Updated: November 19th 2024

FDA Approves Revumenib for R/R Acute Leukemia With a KMT2A Translocation

What We’re Reading: Concierge Nonprofit Hospitals; Kaiser Permanente Program for Elderly Care; Health Care Not a Top Issue Among Voters

Published: April 1st 2024 | Updated: November 5th 2024

What We're Reading: Concierge Nonprofit Hospitals; Kaiser Permanente Elderly Care Program; Health Care Not Among Top Voter Issues

Clinician giving patient a diagnosis | Image Credit: Pcess609 - stock.adobe.com

Published: October 21st 2024 | Updated: October 24th 2024

Lower Diagnostic Error Rates Found Among Hospitalized Patients During Care Transitions

Hurricane | Image credit: Satoshi Kina - stock.adobe.com

Published: September 26th 2024 | Updated: October 1st 2024

Addressing Natural Disaster Takes Cooperation, Preparation to Ensure Patient Health

Opdivo packaging | Image credit: Bristol Myers Squibb

Published: May 9th 2024 | Updated: May 21st 2024

FDA Accepts Nivolumab Subcutaneous Injection Application, With Potential to Boost Access to PD-1 Inhibitors

Published: November 1st 2024 | Updated: November 21st 2024

Table Multiple Myeloma Trials November 2024

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

Do Not Sell My Information

Terms & Conditions